By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.

AXATILIMAB (AX a TIL i mab) treats graft versus host disease, a condition that can occur after a stem cell transplant. It is often prescribed when other treatment options have not worked well enough or cannot be tolerated. It works by decreasing inflammation. It also prevents the buildup of scar tissue. It is a monoclonal antibody.


There is no lifestyle interaction information available for this medication.